Despite its potential, precision targeting faces several challenges. These include the complexity of designing nanoparticles that can navigate the body's biological barriers, the potential for immune responses against the nanoparticles, and the difficulty in ensuring consistent and controlled release of therapeutic agents. Additionally, there are regulatory and manufacturing hurdles that need to be addressed to bring these advanced treatments to clinical practice.
